Silke Stertz

Has grant

University of Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Novel receptors for host cell entry of influenza A viruses

Open Date: 2021-01-01

Close Date: 2025-01-01

Grant: Close

Infectivity of influenza viruses in expiratory aerosols under ambient temperatures and humidities (IVEA)

Open Date: 2020-01-01

Close Date: 2024-01-01

Grant: Close

Host proteins required for influenza virus entry as novel antiviral targets

Open Date: 2017-11-01

Close Date: 2021-10-31

Grant: Close

Entry and reassortment potential of the newly discovered bat influenza A-like viruses

Open Date: 2016-04-01

Close Date: 2019-04-30

Grant: Close

The role of phosphorylation events during influenza A virus entry

Open Date: 2014-11-01

Close Date: 2017-10-31

Articles (20)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

Anouk Lkharrazi

University of Zurich

SWITZERLAND

View details

Benjamin Hale

Associate Professor

University of Zurich

SWITZERLAND

View details

Ulrich Krieger

Lecturer

ETH Zürich

SWITZERLAND

View details

Christian Gübeli

ETH Zürich

SWITZERLAND

View details

Caroline Tapparel Vu

Associate Professor

University of Geneva

SWITZERLAND

View details

Michael Schotsaert

Rockefeller University

UNITED STATES

View details

Ron Fouchier

Full professor

Erasmus University Rotterdam

NETHERLANDS

View details

Adolfo Garcia-Sastre

Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Robert de Vries

Associate Professor

Utrecht University

NETHERLANDS

View details

Tamar Kohn

Associate Professor

EPFL (École Polytechnique Fédérale de Lausanne)

SWITZERLAND

View details

Peter Horby

Professor of Emerging Infectious Diseases

University of Oxford

UNITED KINGDOM

View details

Sonja Fernbach

Københavns Universitet

DENMARK

View details

Carles Martínez-Romero

Assistant Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Silke Stertz

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

Europe needs a sustainably funded influenza research and response network.

H19 influenza A virus exhibits species-specific MHC class II receptor usage

Dependence of aerosol-borne influenza A virus infectivity on relative humidity and aerosol composition.

Salt Supersaturation as an Accelerator of Influenza A Virus Inactivation in 1 μL Droplets.

Correction for David et al., "Inactivation mechanisms of influenza A virus under pH conditions encountered in aerosol particles as revealed by whole-virus HDX-MS".

Correction for David et al., "Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria".

Impact of organic compounds on the stability of influenza A virus in deposited 1-μL droplets.

Correction to "Expiratory Aerosol pH: The Overlooked Driver of Airborne Virus Inactivation".

MHC class II proteins mediate sialic acid independent entry of human and avian H2N2 influenza A viruses.

Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.

Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense

Expiratory aerosol pH is determined by indoor room trace gases and particle size

Proteomic Identification of Potential Target Proteins of Cathepsin W for Its Development as a Drug Target for Influenza.

Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity.

Unraveling virus-induced cellular signaling cascades by label-free quantitative phosphoproteomics.

Phosphoproteomic profiling of influenza virus entry reveals infection-triggered filopodia induction counteracted by dynamic cortactin phosphorylation.

Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir

An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles.

IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization.

Entry of influenza A virus into host cells - recent progress and remaining challenges.

Collaborators (13)

Anouk Lkharrazi

Benjamin Hale

Ulrich Krieger

Christian Gübeli

Caroline Tapparel Vu

Michael Schotsaert

Ron Fouchier

Adolfo Garcia-Sastre

Robert de Vries

Tamar Kohn

Peter Horby

Sonja Fernbach

Carles Martínez-Romero

Make your next move.